Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid TumorsNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinomaRecruitingPhase 1 / Phase 22026-09-17NCT07407933

3 results · Page 1 of 1

Swipe the table sideways for more columns.

38 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Site 1001Washington D.C.United States1
Site 1002FairfaxUnited States1
Site 1004LouisvilleUnited States1
Site 1005HoustonUnited States1
Site 1009PlantationUnited States1
Site 1201NamurBelgium1
Site 1203EdegemBelgium1
Site 1402NiceFrance1
Site 1403SuresnesFrance1
Site 1404ParisFrance1
Site 1601KalocsaHungary1
Site 1702RavennaItaly1
Site 1703MeldolaItaly1
Site 1705CandioloItaly1
Site 1801PrzemyślPoland1
Site 1802OtwockPoland1
Site 1804PoznanPoland1
Site 1901CraiovaRomania1
Site 1903Cluj-NapocaRomania1
Site 1904BucharestRomania1
Site 2001BarcelonaSpain1
Site 2002MadridSpain1
Site 2003BarcelonaSpain1
Site 2004MadridSpain1
Site 2005MadridSpain1